RenovoRx (RNXT) CFO discloses 25,000 shares bought pre-role

Rhea-AI Filing Summary

RenovoRx, Inc. filed an amended initial ownership report showing that Chief Financial Officer Mark Voll beneficially owns 25,000 shares of the company’s common stock. These shares are held directly and, according to a footnote, were purchased in open‑market transactions before he became CFO.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider VOLL MARK

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 25,000 shares (Direct)

Footnotes (1)

1. F1. The securities were purchased in the open market prior to the Reporting Person's appointment as Chief Financial Officer of the Issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/27/2026 - 07:30 AM Learn about SEC filing dates

FAQ

What does the RenovoRx (RNXT) Form 3/A filing report for Mark Voll?

The Form 3/A shows that Chief Financial Officer Mark Voll beneficially owns 25,000 shares of RenovoRx common stock. It is an amended initial ownership statement, updating the market on his share position as an officer.

How many RenovoRx (RNXT) shares does CFO Mark Voll hold?

CFO Mark Voll is reported as holding 25,000 shares of RenovoRx common stock. These shares are listed as directly owned, giving investors a clear view of his equity stake as reported in this amended ownership filing.

Did Mark Voll buy new RenovoRx (RNXT) shares in this Form 3/A?

No new purchase occurs in this filing; it simply reports an existing 25,000-share position. A footnote explains that these securities were bought in open‑market transactions before his appointment as Chief Financial Officer.

Were the RenovoRx (RNXT) shares held by the CFO bought on the open market?

Yes. A footnote states that the 25,000 RenovoRx common shares were purchased in the open market before Mark Voll became Chief Financial Officer, indicating they were acquired as regular market transactions, not as part of an executive grant.

Does the RenovoRx (RNXT) Form 3/A show direct or indirect ownership for the CFO?

The filing reports that Mark Voll’s 25,000 RenovoRx common shares are held as direct ownership. There is no indication of indirect holdings through entities or trusts in this specific amended ownership statement.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

VOLL MARK

(Last) (First) (Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 320

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026

3. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/24/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	25,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The securities were purchased in the open market prior to the Reporting Person's appointment as Chief Financial Officer of the Issuer.

Remarks:

The Reporting Person is filing this amendment to the Form 3 originally filed on March 24, 2026, to reflect the Reporting Person's correct title as Chief Financial Officer, rather than Chief Executive Officer as inadvertently reported in Footnote 1.

	/s/ Mark Voll	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)